Savillex, LLC has completed its acquisition of Entegris, Inc.’s Life Sciences Fluid Management business, adding a portfolio of single-use bioprocessing and pharmaceutical manufacturing products to its high-purity fluid handling offer.
The acquired business includes Aramus and PE bags, single-use assemblies and components used in discovery, clinical and commercial manufacturing. Savillex said the addition broadens its life sciences portfolio and increases its ability to support customers across drug development and production.
Savillex is based in Eden Prairie, Minnesota, while Entegris is based in Billerica, Massachusetts. The company said the transaction brings an experienced fluid management team and technologies in high-purity single-use processing. Customers are expected to gain access to a wider range of single-use solutions and additional technical expertise.
Eric Giesing, Savillex’s chief executive officer, said the Aramus product line fits with Savillex’s existing containment and bioprocessing offerings. He added that Savillex will continue investing in technologies intended to help customers accelerate development and production of therapies.
Chris Bedi, general manager of fluid management at Savillex, said the portfolio complements Savillex’s existing capabilities and that the combined business will continue to provide innovative solutions while expanding support for partners across drug development.
Savillex said it will continue investing in innovation, quality and customer partnerships as it expands its portfolio for biopharmaceutical and pharmaceutical manufacturers. The company did not disclose the terms of the transaction. EC M&A served as financial advisor and Sidley Austin LLP served as legal counsel to Savillex.